Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.31 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31597506 | 0.79 | ACLY (0.33) | ACLY | |
| SCHEMBL8404404 | 0.79 | ELANE (0.39) | KCNA3ELANEMTNR1AMTNR1B | |
| SCHEMBL30394936 | 0.76 | DYRK1A (0.35) | ACLY | |
| SCHEMBL31040083 | 0.76 | ACLY (0.32) | ACLY | |
| SCHEMBL28172478 | 0.76 | KCNA3 (0.36) | KCNA3ELANEMTNR1AMTNR1B | |
| SCHEMBL12121768 | 0.76 | ELANE (0.37) | KCNA3ELANEMTNR1AMTNR1B | |
| SCHEMBL23022302 | 0.76 | KCNA3 (0.36) | KCNA3ELANEMTNR1AMTNR1B | |
| SCHEMBL29873503 | 0.75 | DYRK1A (0.36) | KCNA3ELANEMTNR1AMTNR1B | |
| SCHEMBL3352320 | 0.71 | ACLY (0.42) | ELANEACLYMTNR1AMTNR1B | |
| SCHEMBL12121764 | 0.71 | KCNA3 (0.35) | KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021195183-A1 | COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE | EXO THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |